NTRK1 and nonpapillary renal cell carcinoma: These factors in turn may activate the PI3K/AKT pathway via receptor tyrosine kinases (RTKs), leading to subsequent activation of mammalian target of rapamycin complex 1 (mTORC1) mTORC2, which then further promote HIF expression to contribute to ccRCC [9, 34].